glucose, (beta-d)-isomer has been researched along with pentoxifylline in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crouch, SP; Fletcher, J | 1 |
| Bedö, Z; Sonkoly, I; Szabó, G; Szegedi, G; Szekanecz, Z | 1 |
| Andres, DW; Doerschuk, CM; Doyle, NA; Kutkoski, GJ; Quinlan, WM | 1 |
| Asaka, S; Nakata, K; Shibayama, Y | 1 |
| Chang, FY; Shaio, MF | 1 |
| Andrioli, G; Bambara, LM; Bellavite, P; Biasi, D; Bonazzi, ML; Caramaschi, P; Carletto, A; Lussignoli, S | 1 |
| Martinez, JR; Sun, X; Zhang, GH | 1 |
| Benevides, VM; Brito, GA; Cunha, FQ; da Rocha, FA; Ferreira, SH; Poole, S; Ribeiro, RA; Sachs, D; Vale, ML | 1 |
| Goris, RJ; Hendriks, T; Volman, TJ | 1 |
| Marshall, JC | 1 |
| Lee, P; Prasad, K | 1 |
11 other study(ies) available for glucose, (beta-d)-isomer and pentoxifylline
| Article | Year |
|---|---|
Effect of ingested pentoxifylline on neutrophil superoxide anion production.
Topics: Administration, Oral; Antigens, CD; CD18 Antigens; Cell Adhesion Molecules; Humans; Lactoferrin; Macrophage-1 Antigen; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Respiratory Burst; Superoxides; Xanthines; Zymosan | 1992 |
Effect of pentoxifylline on decreased in vitro mononuclear leucocyte chemotaxis in vascular and polysystemic autoimmune diseases.
Topics: Adult; Arteriosclerosis Obliterans; Autoimmune Diseases; Chemotaxis, Leukocyte; Female; Humans; In Vitro Techniques; Lupus Erythematosus, Systemic; Male; Middle Aged; Neutrophils; Pentoxifylline; Zymosan | 1991 |
Effect of pentoxifylline on changes in neutrophil sequestration and emigration in the lungs.
Topics: Animals; Blood Cell Count; Cell Movement; Leukocyte Count; Lung; Neutropenia; Neutrophils; Pentoxifylline; Plasma; Pneumonia, Staphylococcal; Rabbits; Zymosan | 1995 |
Role of activated macrophages in augmentation of endotoxin hepatotoxicity.
Topics: Animals; Chemical and Drug Induced Liver Injury; Endotoxins; Liver Diseases; Macrophage Activation; Male; Necrosis; Pentoxifylline; Rats; Rats, Wistar; Zymosan | 1994 |
Pentoxifylline pretreatment enhances the oxidative burst activity of human peripheral blood mononuclear cells.
Topics: Acridines; Adjuvants, Immunologic; Humans; Leukocytes, Mononuclear; Luminescent Measurements; Neutrophil Activation; Neutrophils; Opsonin Proteins; Pentoxifylline; Respiratory Burst; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1996 |
Studies of skin-window exudate human neutrophils: increased resistance to pentoxifylline of the respiratory burst in primed cells.
Topics: Cyclic AMP; Dose-Response Relationship, Drug; Drug Resistance; Humans; In Vitro Techniques; Inflammation; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Respiratory Burst; Skin Window Technique; Superoxides; Zymosan | 1997 |
Inhibition of Ca2+ influx by pentoxifylline in NR8383 alveolar macrophages.
Topics: Animals; Calcium Channels; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Diglycerides; Enzyme Activation; Flavonoids; Humans; Macrophages, Alveolar; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate; Zymosan | 1999 |
Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain.
Topics: Acetic Acid; Animals; Arthritis, Experimental; Carrageenan; Hot Temperature; Hyperalgesia; Iloprost; Immunohistochemistry; Inflammation; Interleukin-1; Joints; Male; Mice; Pain; Pain Measurement; Pentoxifylline; Peritoneal Cavity; Phosphodiesterase Inhibitors; Physical Stimulation; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Zymosan | 2004 |
Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome.
Topics: Animals; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Double-Blind Method; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Pentoxifylline; Random Allocation; Survival Analysis; Vasodilator Agents; Zymosan | 2005 |
Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome?
Topics: Animals; Disease Models, Animal; Immunologic Factors; Mice; Multiple Organ Failure; Pentoxifylline; PPAR gamma; Prostaglandin D2; Vasodilator Agents; Zymosan | 2005 |
Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism.
Topics: Animals; Antioxidants; Aorta; Atherosclerosis; Body Weight; Butylene Glycols; Cholesterol, Dietary; Female; Glucosides; Hypercholesterolemia; Lipids; Luminescence; Malondialdehyde; Pentoxifylline; Rabbits | 2007 |